Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    "Buerger disease"
Show Display Options
Rank Status Study
1 Completed Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease
Condition: Buerger's Disease
Intervention: Biological: RNL-Vascostem®
2 Completed A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Conditions: Critical Limb Ischemia;   Buerger's Disease
Intervention: Biological: Allogeneic Mesenchymal Stem Cells
3 Completed Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan
Condition: Thromboangiitis Obliterans
Intervention: Drug: Bosentan
4 Completed ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease
Conditions: Thromboangiitis Obliterans;   Atheromatous Arteritis
Intervention:
5 Unknown  TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
Conditions: Buerger Disease;   Arteriosclerosis Obliterans
Intervention: Procedure: Autologous Bone Marrow Mononuclear Cell Implantation
6 Completed Contrast Enhanced Ultrasound and Muscle
Conditions: Ischemia;   Thromboangiitis Obliterans
Intervention: Other: contrast echographie with hexafluorur of sulfur
7 Unknown  Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
Conditions: Critical Limb Ischemia;   Peripheral Arterial Disease;   Buerger's Disease
Interventions: Device: ResQ processed bone marrow sample;   Device: Ficoll conventional cell processing method
8 Recruiting Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
Conditions: Thromboangiitis Obliterans;   Arteritis;   Peripheral Arterial Disease
Interventions: Other: autologous purified CD34+ cells;   Other: autologous peripheral blood mononuclear cells
9 Not yet recruiting Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
Condition: Critical Limb Ischemia (CLI)
Interventions: Biological: CLBS12;   Drug: SOC
10 Enrolling by invitation Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
Conditions: Critical Limb Ischemia;   Arteriosclerosis Obliterans;   Peripheral Arterial Disease;   Thromboangiitis Obliterans;   Diabetic Angiopathies
Interventions: Procedure: ADRC injection;   Other: ADRC isolation;   Procedure: Liposuction
11 Completed Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
Condition: Critical Limb Ischemia
Intervention: Other: Endothelial progenitor cells intramuscular implant

Study has passed its completion date and status has not been verified in more than two years.